Masimo is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and connectivity solutions. In 1995, Masimo debuted SET® Measure-through Motion and Low Perfusion™ pulse oximetry, estimated to be used on more than 100 million patients annually. In 2005, Masimo introduced rainbow® Pulse CO-Oximetry, allowing noninvasive and continuous monitoring of additional physiologic parameters that previously could only be measured invasively, such as total hemoglobin (SpHb®). We continue to advance noninvasive monitoring, connectivity, and automation with innovations like the Root® patient monitoring and connectivity hub and the Patient SafetyNet™ supplemental remote monitoring solution.
Advanced Diagnostics and Physiological Monitoring in Critical Care Symposium 2021
6-7 August 2021, Brisbane Convention & Exhibition Centre, Merivale St & Glenelg St, South Brisbane QLD
#ADPMoCC2021
www.diagnosticsandmonitoringcritcare2021.com
Iceberg Events | PO Box 1179, Milton Qld Australia | Phone 07 3876 4988